The latest News Headlines from the Scientific, Research and HighTech world

Články z PhysOrgWomen with certain type of ovarian cancer and BRCA gene mutation have improved survival at 5 years

24. 1 2012 (22:24)

Among women with invasive epithelial ovarian cancer, patients having a germline (gene change in a reproductive cell that could be passed to offspring) mutation in the BRCA1 or BRCA2 genes was associated with improved 5-year overall survival, with BRCA2 carriers having the best prognosis, according to a study in the January 25 issue of JAMA.